What is Affinia Therapeutics worth?
$145.0Mlast known valuation
Affinia Therapeutics last raised $13.3M in its Early Stage VC (Sep 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Affinia Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Early Stage VC | $13.3M | ▮ | ▮ |
| Apr 2021 | Later Stage VC | $110.0M | ▮ | ▮ |
| Mar 2020 | Early Stage VC | $38.5M | ▮ | ▮ |
How Affinia Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Affinia Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Affinia Therapeutics worth?
- Affinia Therapeutics's last known valuation is $145.0M.
- How much has Affinia Therapeutics raised?
- Affinia Therapeutics has raised $210.0M in total funding across 3 recorded rounds.
- When did Affinia Therapeutics last raise?
- Affinia Therapeutics last raised in Sep 2025 (Early Stage VC), raising $13.3M.